Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2023 · 10-Q
Revenue$269.66M$269.66M+4.6% vs Q1 2022 Net Income$89.56M$89.56M+28.6% vs Q1 2022 EPS Diluted$0.55$0.55−67.5% vs Q1 2022 Gross Profit$179,595,000+5.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$56,081,000+15.8% Free Cash Flowderived$46,525,000+9.8% Margins · derivedGross margin66.6%+0.3 pt vs Q1 2022
Operating margin20.9%−3.6 pt vs Q1 2022
Net margin33.2%+6.2 pt vs Q1 2022
ended Sep 30, 2022 · filed Nov 7, 2022 · 38 d after period end